Because there will be no single solution to stopping HIV, having multiple prevention options is not simply a best-case scenario, it is the only scenario that can end the epidemic. This is especially true for women, who bear the brunt of the epidemic.

IPM has focused on investigating delivery mechanisms that are “coitally independent,” meaning the microbicide could be applied once a day or even less frequently, independent of the time of sex. 

Our most clinically advanced formulation is a long-acting vaginal ring that slowly releases the ARV dapivirine over the course of a month.

We undertake each formulation project with the needs and expectations of women in mind, based on the preferences they express in qualitative studies.